Hyderabad: The country’s first potential COVID-19 vaccine has received the green light from Drug Controller General of India (DCGI) for Phase I and II human clinical trials.
The trials will begin across the country in July.
The vaccine, COVAXIN, has been developed by Hyderabad-based Bharat Biotech, in association with Indian Council for Medical Research (ICMR). It is an inactivated vaccine created from a strain of the infectious SARS-CoV-2 virus.
The vaccine has shown promising results in preclinical studies, demonstrating extensive safety and effective immune responses.
Globally, AstraZeneca’s vaccine followed by Moderna’s are in the lead with the latter scheduled to conduct Phase III trials from mid-July.
AstraZeneca, which has developed the vaccine with the help of researchers at the University of Oxford, has started large-scale mid-stage human trials.
China too has developed a vaccine in association with CanSino Biologics, which shows promising results in early clinical trials.
Mumbai: After beau Arjun Kapoor declared publicly that he is not dating anyone right now,…
Mumbai: Even though Aishwarya Rai and Abhishek Bachchan have maintained a dignified silence over their…
Bhubaneswar: Siddhant Das has sought to step down as Chairman of Odisha Real Estate Regulatory…
Hyderabad: Odisha FC went on a scoring spree at the Gachibowli Stadium as they humbled hosts…
Mumbai: Filmmaker Anurag Kashyap’s directorial debut ‘Paanch’ is finally going to see the light of…
Mumbai: Actress Taapsee Pannu, who has shared screen space with very few A-listers, has now…
Bhubaneswar: Vigilance has arrested a Forester and a Gaon Sathi (village mate) for alleged misappropriation…
Mumbai: Ten days ago, Vaibhav Suryavanshi made headlines after becoming the youngest cricketer to make…